Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Account Payables
Amounts the company owes suppliers for goods and services received.
Account Payables history
Currency unavailable · from the balance sheet
No Account Payables data reported for this period type.
Account Payables vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $7.12M USD | +1021.1% | +138.9% | 1.8% |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $6.56M USD | +206.7% | +42.4% | 1.3% |
| Mar 2026 | $5.21M USD | +9.2% | +26.4% | 1.9% | |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $5.06M USD | +380.7% | -22.1% | 3.3% |
| Mar 2026 | $4.47M USD | -25.3% | -27.0% | 1.0% | |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $1.5M USD | -59.0% | +33.2% | 0.6% |
| Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +9.2% | +29.8% | 1.3% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.